Clorox gains after earnings topper, points to 'challenging' cost backdrop (CLX:NYSE)

Clorox Co. (CLX) reported fiscal Q1 net income of $170M, or $1.39 per share, exceeding analyst expectations of $0.97 per share. Revenue was $1.91B, surpassing forecasts of $1.87B. The company expects full-year earnings of $5.70 to $6 per share.

Clorox (NYSE:CLX) reported Q3 CY2026 revenue of $1.91B, up 33.3% YoY and 1.5% above estimates. Adjusted EPS of $1.55 beat estimates by 44.6%. Management reiterated full-year EPS guidance of $5.85 at the midpoint. Organic revenue rose 18% YoY. CEO Linda Rendle cited strong execution and timing benefits but noted higher inflationary pressures. Shares rose 2.1% post-results.

Clorox reported $1.91B in Q1 sales, up 33% YoY, driven by its GOJO acquisition. Organic sales rose 18%, while gross margin fell to 40.4% due to higher costs. EPS increased 114% to $1.39. CEO Linda Rendle noted results exceeded expectations but highlighted higher inflationary pressures.

Upwork shares rose 11% after raising full-year earnings guidance. Palantir's Q3 revenue nearly doubled, surpassing $2B. Lattice Semiconductor's stock jumped 7% on strong Q3 results and raised forecast. Clorox gained 2% with Q1 earnings beating estimates. On Semiconductor fell 2% after announcing a $600M acquisition and Q4 guidance. Apple's Q4 revenue rose 12% to $114.48B, but iPad sales declined. Fabrinet surged 12% on strong Q2 guidance.

Clorox (CLX) reported Q1 adjusted EPS of $1.55, beating estimates by $0.48, with revenue at $1.91B, up 33% YoY. Shares rose 2%. Growth was driven by the GOJO acquisition and last year's inventory adjustments, but higher costs compressed margins. The company maintained FY2027 guidance, expecting EPS near the low end of the range.

Clorox reported Q1 Non-GAAP EPS of $1.55, exceeding estimates by $0.48. Revenue reached $1.91B, up 33.6% YoY, with organic sales increasing 18%. The GOJO acquisition contributed about 15 points to growth, according to the company.